Microfluidic Bioreactor with Fibrous Micromixers for In Vitro mRNA Transcription
Source abstract
Abstract
A new type of microfluidic bioreactor with fibrous micromixers for the ingredient mixing and a long macrochannel for the in vitro transcription reaction was fabricated for the continuous production of mRNA. The diameter of the fibrous microchannels in the micromixers was tuned by using an electrospun microfibrous disc with different microfiber diameters. The micromixer with a larger diameter of fibrous microchannels exhibited a better mixing performance than the others. The mixing efficiency was increased to 0.95 while the mixture was passed through the micromixers, suggesting complete mixing. To demonstrate the continuous production of mRNA, the ingredients for in vitro transcription were introduced into the perfluoropolyether microfluidic bioreactor. The mRNA synthesized by the microfluidic bioreactor had the same sequence and in vitro/in vivo performances as those prepared by the bulk reaction. The continuous reaction in the microfluidic bioreactor with efficient mixing performance can be used as a powerful platform for various microfluidic reactions.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Microfluidic and Capillary Electrophoresis Applications · Innovative Microfluidic and Catalytic Techniques Innovation · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Biomedical and Chemical Engineering, The Catholic University of Korea, 43 Jibong-ro, Bucheon-si, Gyeonggi-do 14662, Republic of Korea
Department of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Bucheon-si, Gyeonggi-do 14662, Republic of Korea
Department of Medical and Biological Sciences, The Catholic University of Korea, 43 Jibong-ro, Bucheon-si, Gyeonggi-do 14662, Republic of Korea
Funding
National Research Foundation of Korea
References (42)
Show source-provided references
1. 10.1016/j.trsl.2021.11.00910.1016/j.trsl.2021.11.009 ↗
2. 10.4161/rna.2226910.4161/rna.22269 ↗
3. 10.1002/bit.2821610.1002/bit.28216 ↗
4. 10.1002/cite.20220013310.1002/cite.202200133 ↗
5. 10.1016/j.vaccine.2021.03.03810.1016/j.vaccine.2021.03.038 ↗
6. 10.3390/pharmaceutics1309137110.3390/pharmaceutics13091371 ↗
7. 10.1155/2012/75016210.1155/2012/750162 ↗
8. 10.1016/S0009-2509(05)80004-110.1016/S0009-2509(05)80004-1 ↗
9. 10.1002/pc.2363110.1002/pc.23631 ↗
10. 10.1038/s41598-018-26542-x10.1038/s41598-018-26542-x ↗
11. 10.1017/S002211200500499410.1017/S0022112005004994 ↗
12. 10.1002/masy.20095053010.1002/masy.200950530 ↗
13. 10.3390/mi809027410.3390/mi8090274 ↗
14. 10.1088/0960-1317/15/2/R0110.1088/0960-1317/15/2/R01 ↗
15. 10.1039/C5LC00173K10.1039/C5LC00173K ↗
16. 10.1016/j.sna.2014.02.01510.1016/j.sna.2014.02.015 ↗
17. 10.1038/s41378-020-0166-y10.1038/s41378-020-0166-y ↗
18. 10.1016/j.cep.2016.11.00310.1016/j.cep.2016.11.003 ↗
19. 10.3390/mi1204037210.3390/mi12040372 ↗
20. 10.1186/s40580-017-0098-x10.1186/s40580-017-0098-x ↗
21. 10.3390/mi903010710.3390/mi9030107 ↗
22. 10.1073/pnas.040584710110.1073/pnas.0405847101 ↗
23. 10.1007/s11426-012-4808-210.1007/s11426-012-4808-2 ↗
24. 10.3390/mi504091310.3390/mi5040913 ↗
25. 10.3390/mi607095310.3390/mi6070953 ↗
26. 10.3390/mi608116610.3390/mi6081166 ↗
27. 10.1039/C005325M10.1039/C005325M ↗
28. 10.3390/mi601013610.3390/mi6010136 ↗
29. 10.1016/j.cej.2009.05.03510.1016/j.cej.2009.05.035 ↗
30. 10.1007/s00542-017-3516-410.1007/s00542-017-3516-4 ↗
31. 10.1016/j.ces.2021.11700610.1016/j.ces.2021.117006 ↗
32. 10.1007/s10404-021-02478-z10.1007/s10404-021-02478-z ↗
33. 10.1007/s00604-011-0567-610.1007/s00604-011-0567-6 ↗
34. 10.1021/acsmacrolett.1c0074910.1021/acsmacrolett.1c00749 ↗
35. 10.4014/jmb.1811.1101910.4014/jmb.1811.11019 ↗
36. 10.1016/j.cep.2021.10860910.1016/j.cep.2021.108609 ↗
37. 10.1088/1742-6596/923/1/01203310.1088/1742-6596/923/1/012033 ↗
38. 10.1016/j.cej.2010.12.03510.1016/j.cej.2010.12.035 ↗
39. 10.3390/mi1011078610.3390/mi10110786 ↗
40. 10.3390/mi1105045510.3390/mi11050455 ↗
41. Yoon J.-Y. · 2008 · 6810.1007/978-0-387-48998-8_87 ↗
42. 10.1038/s41598-019-43625-510.1038/s41598-019-43625-5 ↗